What you pay for a cystatin C test depends far more on how it is ordered than on the marker itself. The price is set by the panel it sits inside, the laboratory running the assay, whether a clinician order and interpretation are included, and how your health plan treats the reason for testing.
FitScript includes cystatin C in its Organ Health panel, and the current price is shown with the panel details on this page rather than written into this article, because catalog pricing changes.
Cystatin C is a small protein produced at a fairly constant rate by nearly all nucleated cells, filtered freely by the glomeruli and then taken up and broken down by the kidney tubules, so its blood concentration reflects how well the kidneys are filtering 1. The lab reports a concentration, usually in mg/L, and most reports also convert that concentration into an estimated glomerular filtration rate (eGFR) using a validated equation. The marker page for Cystatin C covers the biology in more detail.
Because the protein comes from cells throughout the body rather than from muscle tissue, it behaves differently from creatinine, which is a by-product of muscle metabolism. Research suggests that cystatin C is less dependent on muscle mass, diet and age than creatinine, which is the main reason it was investigated as an alternative filtration marker in the first place 2. It has influences of its own, including thyroid status, inflammation, body fat and corticosteroid exposure, and a careful review of the marker treats those as real limits rather than footnotes 3.
Reference ranges differ between laboratories because assays and calibration differ. Ranges vary by lab, age and sex, so read your number against the range printed on your own report.
It gives a second, independent estimate of filtration that does not share creatinine's main blind spot, and the agreement between the two estimates is itself useful information.
| Estimate | What drives the number | Where it can mislead |
|---|---|---|
| eGFR from creatinine | A muscle breakdown product cleared mainly by filtration | Very high or very low muscle mass, limb loss, high meat intake, some medications that affect tubular secretion |
| eGFR from cystatin C | A protein produced by most nucleated cells and cleared by filtration | Thyroid disease, systemic inflammation, higher body fat, some medicines |
| Combined equation using both | Averages two markers with different non-filtration influences | Costs more to run and still estimates rather than measures filtration |
The practical value shows up when the two disagree. A 2025 meta-analysis in JAMA reported that a large gap between creatinine-based and cystatin C-based eGFR is associated with higher rates of adverse clinical outcomes, which makes discordance something a clinician will want to look at rather than average away 4. Newer estimating equations have been developed and compared with this in mind, including work on the European Kidney Function Consortium equation and how creatinine, cystatin C and combined approaches perform against each other 5.
None of this makes either marker a diagnosis. An eGFR is an estimate of a physiological rate, and a single estimate on a single day is a snapshot.
Most often when a creatinine-based estimate is likely to be unreliable, or when a decision depends on getting the filtration estimate closer to right.
That includes people whose body composition sits at the extremes, since a lean older adult and a heavily muscled lifter can both have creatinine values that misrepresent their filtration. It also includes confirmation testing, where a borderline creatinine-based eGFR is rechecked with a second marker before anything is concluded from it.
Transplant medicine is another setting. Studies suggest that adding cystatin C to creatinine-based equations improves GFR estimation in kidney transplant recipients 6, and the relevance of cystatin C based recommendations in transplant guidance has been examined directly in the transplant literature 7. In paediatrics, where muscle mass changes constantly with growth, cystatin C has been reviewed as a marker of kidney function in children 8, and separate work has looked at its use in newborns alongside the standardization questions that remain open 9.
There is also interest in using a better filtration estimate when medications cleared by the kidneys are involved. Those are clinician decisions made in a clinical context, not something to act on from a lab report.
The marker is a small part of the total. Most of what you pay reflects the packaging around it.
| Factor | Why it moves the price |
|---|---|
| Standalone test or panel | Panels spread the fixed costs of a draw, handling and reporting across many markers, so the per marker cost falls as the panel grows |
| Assay and instrument | Cystatin C is measured by immunoassay rather than the simple chemistry used for creatinine, and less routine assays cost more to run |
| Whether a clinician order is included | Some routes require a separate consultation to generate the order, which is billed on its own |
| Whether interpretation is included | A raw number costs less than a number delivered with context, trending and follow up |
| Where blood is drawn | Patient service centres, mobile phlebotomy and in clinic draws carry different overheads |
| Billing route | Cash or membership pricing, insurance billing and reference lab pricing are three different price lists for the same analyte |
| Testing frequency | A one-off test and a programme of repeat testing across a year are priced on different logic |
This is why quoting one number for a cystatin C test is misleading. The same analyte can be a line item in a broad panel or a separately ordered send out test, and those are not comparable purchases.
Coverage varies by plan and by why the test is ordered, so check with your plan before you assume either outcome. Tests ordered to investigate a documented clinical problem are generally handled differently from tests ordered for screening or self-directed health optimization, and plans differ on where they draw that line. No article can tell you how your specific plan will adjudicate a specific claim.
The FitScript Organ Health panel is marked HSA and FSA eligible in the catalog, which means pre-tax funds can generally be used for it. Your plan administrator sets the rules for what your account reimburses, so confirm with them if the distinction matters to your budget.
Cystatin C is not sold as a standalone marker in the FitScript catalog. It sits inside the Organ Health panel, which groups kidney filtration markers with liver and related chemistry so that one blood draw produces a picture of organ function rather than an isolated value. The full marker list and the current price appear with the panel details on this page.
The wider membership tests 150+ biomarkers tested per year, and results are interpreted by Atlas, the AI health advisor, which reads each marker against your other results and your history rather than in isolation. Where a result points toward something that needs clinical attention, a licensed provider evaluates whether any treatment is appropriate. Nothing on a lab report substitutes for that evaluation.
Follow the preparation notes shown with the panel, since other markers drawn in the same tube may have requirements that cystatin C itself does not. Beyond that, the goal is consistency rather than special effort.
Keep your hydration normal, because arriving significantly dehydrated can shift several chemistry markers at once. Keep the timing of the draw similar from one test to the next if you plan to trend results over the year, since comparing a morning draw with an afternoon draw adds noise you do not need. Note any supplements and medications you take and tell the drawing site, since several can influence chemistry results and your clinician needs that context to read the report properly. If you have been unwell, or have done unusually heavy training in the days before, say so, because acute illness and heavy exercise can both move markers temporarily.
Use the same three steps a clinician does. First, the observation, which is the reported concentration and the eGFR calculated from it, read against your own lab's reference range. Second, the possible meaning, which is where filtration appears to sit and whether the cystatin C based estimate agrees with the creatinine based one. Third, the next step, which is a conversation rather than a conclusion.
A value outside the standard range is suboptimal, not a diagnosis, and a single reading can be moved by illness, inflammation, thyroid status or a hard training block. A repeat test some weeks later, interpreted alongside creatinine, urine albumin and the rest of the picture, tells you far more than one number ever will. If a result sits well outside the reference range, or if the two eGFR estimates disagree substantially, that is worth discussing with a clinician promptly rather than watching on your own. Never ignore an abnormal result, and never stop or start anything on the strength of one lab value.
If you want the longer comparison between the two markers, see why is cystatin c better than creatinine, and the marker list, HSA and FSA eligibility and current price for the panel that includes it sit on the Organ Health page.
This page is educational and is not medical advice. Discuss your results, and any treatment decision that follows from them, with a clinician or licensed provider.
There is no single figure, because the marker is almost always priced as part of a panel rather than on its own. What you pay reflects the panel it sits in, the laboratory and assay used, whether a clinician order and interpretation are included, and how the test is billed. The current price for the FitScript Organ Health panel, which includes cystatin C, is shown with the panel details on this page.
Creatinine is measured with routine clinical chemistry that runs on almost every analyser, while cystatin C is measured by immunoassay, which is a less routine method with different reagent and calibration costs. That difference in method, rather than anything about the biology, is a large part of why the two markers sit at different points on a lab's price list.
Coverage varies by plan and by why the test is ordered, so check with your plan before assuming either way. Testing ordered to investigate a documented clinical problem is often handled differently from testing ordered for screening or self-directed health optimization, and plans draw that line in different places.
The FitScript Organ Health panel that includes cystatin C is marked HSA and FSA eligible in the catalog, so pre-tax funds can generally be used for it. Your account administrator sets the final rules on reimbursement, so confirm with them if that matters to how you plan the purchase.
A laboratory test needs a valid clinician order behind it. Some routes require you to arrange a separate consultation to obtain one, which is billed on its own and adds to the total. Membership based testing usually handles the ordering as part of the service, which is one reason the headline numbers are hard to compare between providers.
Follow the preparation notes shown with the panel details, because other markers drawn in the same appointment may have requirements that cystatin C itself does not. Beyond that, stay normally hydrated, keep the timing of repeat draws consistent, and tell the drawing site about medications and supplements you take.
No. The two markers have different non-filtration influences, and most current guidance treats them as complementary rather than interchangeable. The disagreement between a creatinine-based estimate and a cystatin C-based estimate carries information of its own, which is lost if only one marker is measured.
Thyroid status, systemic inflammation, higher body fat and some medicines have all been described as influences on the marker. That is why a single value is read in context, alongside creatinine, urine findings and your history, rather than taken as a standalone verdict on kidney function.
Treat it as suboptimal rather than diagnostic, and take it to a clinician. A single reading can be shifted by illness, inflammation or a heavy training block, so a repeat test interpreted alongside your other kidney markers is usually the next step. If the value sits well outside the range, discuss it with a clinician promptly rather than waiting.